Centro Oncologico MD Anderson

Madrid 28033

0 studies enrolling now · 6 studies all time

What they study most

Breast Cancer, Cancer, Disease, Hodgkin, HER2+ Metastatic Breast Cancer (MBC), MET Gene Amplification, MET Gene Mutation, NSCLC, Non Small Cell Lung Cancer, Oncology, Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53

Studies at this site

• Met Non Small Cell Cancer Registry (MOMENT) — Recruiting now
• p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246 — Completed
• Sym015 (Anti-MET) in Patients With Advanced Solid Tumor Malignancies — Completed
• A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting — Completed
• A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial) — Completed
• Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer — Completed